Open Interest and Volume Dynamics
On 22 May 2026, Alkem Laboratories recorded an open interest (OI) of 18,499 contracts, up from 15,687 the previous day, marking an increase of 2,812 contracts or 17.93%. This rise in OI was accompanied by a futures volume of 13,694 contracts, indicating robust trading activity in the derivatives market. The combined futures and options value stood at approximately ₹5,22,48.76 lakhs, with futures contributing ₹51,977.01 lakhs and options an overwhelming ₹4,306,012.90 lakhs, underscoring significant investor interest in hedging or speculative positions.
The underlying stock price closed at ₹5,438, reflecting a 1.05% decline on the day, underperforming its sector by 0.49% and the broader Sensex, which gained 0.28%. Despite this, the stock remains above its 50-day moving average but below its 5-day, 20-day, 100-day, and 200-day averages, suggesting a mixed technical picture with short-term weakness amid longer-term support.
Market Positioning and Investor Behaviour
The surge in open interest alongside elevated volumes suggests that market participants are actively repositioning themselves. The increase in OI typically indicates that new money is entering the market, either through fresh long or short positions. Given the stock’s recent downgrade from a mojo grade of Hold to Sell on 11 May 2026, investors may be taking directional bets anticipating further downside or volatility.
Supporting this, delivery volumes have fallen sharply by 27.89% compared to the five-day average, with only 28,770 shares delivered on 21 May. This decline in investor participation at the delivery level contrasts with the heightened derivatives activity, implying that traders are favouring short-term speculative or hedging strategies over outright stock accumulation.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Directional Bets and Derivatives Strategy
The substantial open interest increase in Alkem’s derivatives market may be indicative of directional bets, with traders positioning for potential price moves. The futures value of ₹51,977 lakhs and options value exceeding ₹4,306 crores highlight significant capital allocation towards this stock’s derivatives.
Given the stock’s recent mojo downgrade to Sell with a score of 47.0, market participants might be anticipating further downside or increased volatility. The downgrade from Hold on 11 May 2026 reflects deteriorating fundamentals or technical outlook, which could be driving speculative short positions or protective put buying in options.
However, the stock’s mid-cap status and liquidity profile, with a tradable size of approximately ₹1.01 crore based on 2% of the five-day average traded value, ensure that these positions can be established and unwound without excessive market impact.
Sector and Market Context
Alkem Laboratories operates within the Pharmaceuticals & Biotechnology sector, which has seen mixed performance recently. The sector’s one-day return of -0.99% contrasts with the Sensex’s modest gain, indicating sector-specific pressures. Alkem’s underperformance relative to its sector by 0.49% on the day further emphasises the challenges it faces.
Investors should note that while the stock remains above its 50-day moving average, it is trading below other key moving averages, signalling a cautious technical stance. The falling delivery volumes suggest waning long-term investor conviction, while the surge in derivatives activity points to increased short-term trading interest.
Considering Alkem Laboratories Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this mid-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Implications for Investors
The sharp rise in open interest combined with subdued price performance and a recent downgrade suggests that investors should approach Alkem Laboratories with caution. The derivatives market activity points to increased speculation or hedging, which often precedes heightened volatility.
Investors with a medium to long-term horizon may want to monitor the stock’s ability to hold above its 50-day moving average and watch for any reversal in delivery volumes as a sign of renewed investor confidence. Conversely, short-term traders might find opportunities in the increased options and futures activity, capitalising on directional moves or volatility spikes.
Given the mid-cap classification and liquidity profile, Alkem remains accessible for both institutional and retail investors, but the current mojo grade of Sell advises prudence.
Conclusion
Alkem Laboratories Ltd’s recent surge in open interest by nearly 18% amid falling delivery volumes and a downgrade in mojo rating paints a complex picture of market sentiment. While the stock shows technical support at the 50-day moving average, the derivatives market activity signals increased speculative positioning and potential directional bets. Investors should weigh these factors carefully, balancing the stock’s fundamentals, sector dynamics, and technical indicators before making investment decisions.
Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →
